Ligand validation:8XZZ

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 8XZZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XZZ_XYP_B_203	93%	89%	0.053	0.965	0.21	0.43	-	-	0	0	90%	0.9
8XZZ_XYP_C_202	91%	90%	0.057	0.959	0.18	0.43	-	-	0	0	90%	0.9
8XZZ_XYP_D_203	86%	75%	0.063	0.948	0.24	0.71	-	-	0	0	90%	0.9
8XZZ_XYP_B_204	67%	40%	0.094	0.9	0.49	1.82	-	3	0	0	100%	1
8XZZ_XYP_C_201	50%	66%	0.104	0.854	0.23	1.04	-	1	0	0	100%	1
8XZZ_XYP_D_204	42%	67%	0.128	0.845	0.2	1.05	-	1	0	0	100%	1
8Y00_XYP_D_201	99%	28%	0.032	0.986	0.63	2.19	-	7	1	0	90%	0.9
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	0.9
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
1V0N_XYP_A_1306	98%	60%	0.048	0.989	0.76	0.78	-	-	0	0	90%	0.9
1V0L_XYP_A_1305	98%	72%	0.055	0.992	0.52	0.57	-	-	0	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.